Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Steger

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Breast Cancer Research and Treatment|August 10, 2000
Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patientsM Müller, J Bockenheimer, U Zellenberg, et al.
Electrophoresis|December 31, 1998
Analysis of microdialysates from cancer patients by capillary electrophoresisR M Mader, M Brunner, B Rizovski, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancerG G Steger, C Dittrich, O Schlappack, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancerR M Mader, H Zilg, O Schlappack, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 13, 2001
Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancerJ Friedl, A Stift, P Paolini, et al.
Experimental Cell Research|September 21, 2010
Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620I K Tentes, W M Schmidt, G Krupitza, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trialM Hejna, W J Köstler, M Raderer, et al.
Anti-Cancer Drugs|June 1, 2000
Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancerT Brodowicz, W J Koestler, S Tomek, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
Breast Cancer Research and Treatment|June 1, 1995
Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?G J Locker, I Simonitsch, R M Mader, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|August 10, 2000
Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patientsM Müller, J Bockenheimer, U Zellenberg, et al.
Electrophoresis|December 31, 1998
Analysis of microdialysates from cancer patients by capillary electrophoresisR M Mader, M Brunner, B Rizovski, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancerG G Steger, C Dittrich, O Schlappack, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancerR M Mader, H Zilg, O Schlappack, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 13, 2001
Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancerJ Friedl, A Stift, P Paolini, et al.
Experimental Cell Research|September 21, 2010
Long-term persistence of acquired resistance to 5-fluorouracil in the colon cancer cell line SW620I K Tentes, W M Schmidt, G Krupitza, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trialM Hejna, W J Köstler, M Raderer, et al.
Anti-Cancer Drugs|June 1, 2000
Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancerT Brodowicz, W J Koestler, S Tomek, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
Breast Cancer Research and Treatment|June 1, 1995
Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?G J Locker, I Simonitsch, R M Mader, et al.
Pageof 7